http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20054002-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
filingDate 2005-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb8e7da4201b4655c7331cdf661bf3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09cf776842e511bd4a18025cbf223aaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3494b0f678d62fcb112e3d8e95a8ef9
publicationDate 2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20054002-L
titleOfInvention Treatment for diarrhea-predominantly irritable bowel syndrome
abstract Pharmaceutical composition for anti-diarrheal irritable tooth syndrome in male and female patients, containing from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent mole amount of ramosetron or its pharmaceutically acceptable other salt as an active ingredient
priorityDate 2004-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108000

Total number of triples: 19.